GRISANTI, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 4.052
EU - Europa 1.614
AS - Asia 632
AF - Africa 7
SA - Sud America 6
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.317
Nazione #
US - Stati Uniti d'America 4.029
PL - Polonia 363
CN - Cina 362
UA - Ucraina 302
IT - Italia 265
DE - Germania 210
HK - Hong Kong 176
FI - Finlandia 149
IE - Irlanda 113
GB - Regno Unito 77
FR - Francia 45
SE - Svezia 34
VN - Vietnam 32
IN - India 24
CA - Canada 23
BE - Belgio 22
JP - Giappone 15
RU - Federazione Russa 13
NL - Olanda 7
SG - Singapore 7
GR - Grecia 6
IR - Iran 5
AU - Australia 3
BR - Brasile 3
TR - Turchia 3
AZ - Azerbaigian 2
CL - Cile 2
EG - Egitto 2
EU - Europa 2
TW - Taiwan 2
ZW - Zimbabwe 2
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 6.317
Città #
Fairfield 651
Woodbridge 397
Ashburn 380
Warsaw 363
Houston 304
Chandler 275
Seattle 275
Cambridge 258
Jacksonville 223
Wilmington 210
Hong Kong 174
Princeton 144
New York 141
Ann Arbor 138
Helsinki 129
Dublin 81
Beijing 79
Nanjing 60
Brescia 52
Dearborn 44
Shanghai 42
Dong Ket 32
San Diego 32
Nanchang 30
West Jordan 28
Des Moines 27
Washington 25
Brussels 22
Menlo Park 22
Changsha 21
Lancaster 21
Milan 20
Shenyang 20
Jinan 16
Naples 16
Toronto 13
London 12
Hebei 11
San Francisco 11
Tianjin 11
Pune 10
Vignate 10
Gumyojicho 9
Ningbo 9
Taizhou 8
Chicago 7
Falls Church 7
Haikou 7
Kunming 7
Redwood City 7
Rome 7
Zhengzhou 7
Athens 6
Cazzago San Martino 6
Fukuoka 6
Guangzhou 6
Hangzhou 6
Jiaxing 6
Livorno 6
Turin 6
Boardman 5
Lanzhou 5
Perugia 5
Verona 5
Falkenstein 4
Gunzenhausen 4
Leawood 4
New Bedfont 4
North York 4
Norwalk 4
Ottawa 4
Phoenix 4
San Mateo 4
Ardabil 3
Augusta 3
Borås 3
Kocaeli 3
Lappeenranta 3
Nürnberg 3
Rio De Janeiro 3
Rockville 3
Solbiate Olona 3
Treviglio 3
Villa Di Tirano 3
Acton 2
Beinasco 2
Bergamo 2
Berlin 2
Brooklyn 2
Ceto 2
Chiswick 2
Ferrara 2
Gharbia 2
Groningen 2
Gussago 2
Kilburn 2
Leipzig 2
Melbourne 2
Melfi 2
Pianello del Lario 2
Totale 5.074
Nome #
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 175
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 170
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 160
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 159
Immunotherapy failure in adrenocortical cancer: where next? 153
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 143
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 142
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 139
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 139
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 139
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 137
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 137
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 135
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 131
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 124
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 121
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 114
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 114
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 111
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 108
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 108
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 108
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 107
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 106
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 104
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 102
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 101
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 101
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 100
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 98
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 95
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 94
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 92
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 91
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 89
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 89
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 87
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 85
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 85
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 85
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 82
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 81
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 77
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 74
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 72
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 62
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 62
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma 61
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 58
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 53
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 53
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 53
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 51
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 46
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 43
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 43
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 40
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 39
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 37
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 36
Could a comprehensive urinary endogenous steroidal profile improve the accuracy of prostate-specific antigen screening? 36
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 35
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 35
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 34
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 32
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 30
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 28
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 27
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 26
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 26
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 25
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 22
Is BMI a reliable prognostic parameter in metastatic prostate cancer patients? 22
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 21
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 20
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 19
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 18
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 18
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 18
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 16
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 16
Is adjuvant immunotherapy effective in patients with urothelial cancer? 16
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 14
null 14
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 13
Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic Review 13
Lutetium-177-PSMA-617 for Prostate Cancer 13
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 12
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 11
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 11
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: A Systematic Review and Meta-Analysis 10
Lung Carcinoid Tumors: Histology and Ki-67, The Eternal Rivalry 9
Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoids 9
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience 8
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 6
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 6
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 5
Molecular genotyping of adrenocortical carcinoma: A systematic analysis of published literature 2019-2021 5
Is it time to tailor treatments in androgen receptor positive salivary gland cancers? 4
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer 4
Totale 6.508
Categoria #
all - tutte 33.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019352 0 0 0 0 0 0 0 0 0 65 151 136
2019/20201.584 144 54 60 169 118 188 171 179 149 167 80 105
2020/20211.460 48 151 97 193 97 151 49 146 119 197 102 110
2021/2022725 60 57 25 91 22 47 32 45 33 97 53 163
2022/2023739 88 43 41 55 67 168 5 71 110 22 39 30
2023/20241.028 68 40 123 89 98 255 42 78 196 39 0 0
Totale 6.515